Outside the Box: Chinese biotech stocks hit by a double whammy, which means it's time to buy
Have investors hit peak negativity on China-based companies? I think there's a good chance they have. If so, it's time to buy China stocks, especially in biotechnology.
from Biotech News
0 Comments